浅析中医药临床试验研究人员的培训计划

中国药物警戒 ›› 2014, Vol. 11 ›› Issue (4): 222-224.

浅析中医药临床试验研究人员的培训计划

任君, 杨国彦, 韩梅, 刘建平^*

北京中医药大学循证医学中心,北京 100020

收稿日期:2013-11-06 修回日期:2016-02-03 出版日期:2014-04-08 发布日期:2016-02-03
作者简介:任君,女,硕士,循证医学与中医药临床疗效评价。
基金资助:
国家重大新药创制课题“创新药物研究开发技术平台建设-临床评价研究标准化操作规程（SOP）课题”（2011ZX09302-006-

Analysis of Training Programs for Clinical Trial Researchers on Traditional Chinese Medicine

REN Jun, YANG Guo-yan, HAN Mei LIU Jian-ping^*

Center for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100045, China

Received:2013-11-06 Revised:2016-02-03 Online:2014-04-08 Published:2016-02-03

摘要/Abstract

摘要： 研究者的研究能力是关系到中医药临床试验质量和临床试验能否顺利完成的重要组成部分。通过确定培训对象、培训的师资,制定培训目标、培训内容、培训方式和培训考评六个方面,浅析如何根据研究目的和临床试验研究方案制定周密、适用的培训计划,以期进一步规范中医药的临床试验。

关键词: 中医药, 临床研究, 研究人员, 培训计划, 研究能力

Abstract: The competence of clinical trial researchers is essential to assure the quality and accomplishment of clinical trials on traditional Chinese medicine. This paper will discuss how to develop a training program for clinical trial researchers on traditional Chinese medicine, according to the research purpose and protocol, from the following six aspects training participants, objectives, contents, approaches, teachers and evaluation, in order to further standardize the clinical trials of traditional Chinese medicine.

Key words: Chinese medicine, clinical trial, researcher, training program, competence

中图分类号:

任君, 杨国彦, 韩梅, 刘建平. 浅析中医药临床试验研究人员的培训计划[J]. 中国药物警戒, 2014, 11(4): 222-224.

REN Jun, YANG Guo-yan, HAN Mei LIU Jian-ping. Analysis of Training Programs for Clinical Trial Researchers on Traditional Chinese Medicine[J]. Chinese Journal of Pharmacovigilance, 2014, 11(4): 222-224.

参考文献

[1] CFDA. 国家食品药品监督管理局培训中心开展药物临床试验质量管理规范（GCP）网上培训[J].中国药师,2006,9(6):543.
[2] 田少雷,邵庆翔. 药物临床试验与GCP实用指南[M]. 北京：北京大学医学出版社,2010：57.
[3] 刘建平,曹卉娟. 从循证医学看国内发表的中医药临床研究现状及改进策略[J]. 中国中西医结合杂志,2010,30(1):5-8.
[4] 孙塑伦,翁维良,杨龙会.中医临床研究实施过程质控与管理[M].北京：中国中医药出版社,2010：6.
[5] FDA.Use in Medical Product Development to Support Labeling Claims[EB/OL].(2009-12-01)[2013-11-06].http://www.fda.gov/search/Guidance for Industry-patient-Reported Outcome Measures.
[6] 刘建平.中医药临床试验的对照与盲法设置[J].中国中西医结合杂志,2003, 23（10）789-791.
[7] 唐旭东,卞立群,高蕊,等.中药临床试验安慰剂制作探讨[J].中国中西医结合杂志,2009, 29（7）656-658.
[8] 陈美仁,郭翔,李强,等. 针刺手法参数测试仪评判针刺提插法的研究[J].中医药导报,2009, 7(15):53-54.
[9] 黄欣.WHO对传统医学的研究与评价方法论的限定草案[J].国外医学中医中药分册,1999 ,21 (4):58-64.
[10] 王毅,蒋大宗.对经络实质研究中存在问题的讨论[J].针刺研究,2000 ,25(1):72-74.
[11] 陈淑红.美国替代医学的现状展望[J].国外医学中医中药分册,2000 ,22 (4):255-256.
[12] Garvey T A, Marks M R. A prospective, randomized, double- blind evaluation of trigger point injection therapy for low-back pain [J]. Spine ,1989 ,14 (5): 962-966.
[13] Smith L A, Oldman A D, McQuay H J, et al. Teasing apart quality and validity in systematic reviews : an example from acupuncture trials in chronic neck and back pain [J]. Pain, 2000, 86 (2):119-132.
[14] 于强.针灸疗效评价中盲法和安慰剂的选择[J].中西医结合心脑血管病杂志.2003,1（4）：196-198.
[15] 吉林省中医药管理局.中华人民共和国国家中医药管理局-吉林省科研方法培训班[EB/OL]. (2011-07-21 )[2013-11-06].http://www.satcm.gov.cn/e/search/result/?searchid=29131.
[16] U.S. Food and Drug Administration. FDA's Clinical Investigator Training Course[EB/OL]. [2013-11-06].http://www.fda.gov/ScienceResearch/SpecialTopics/CriticalPathInitiative/SpotlightonCP-IProjects/ucm201459.htm.
[17] Clinical investigator training workshop. Clinical investigator training workshop: in collaboration with Society of Clinical Research Professionals Malaysia[EB/OL].[2013-11-06].http://www.crestev-endz.com.my/web/overview.